Effects of Transcutaneous Electrical Nerve Stimulation on Chemotherapy-Induced Peripheral Neuropathy
This phase II trial studies the effects of transcutaneous electrical nerve stimulation (TENS) for the treatment of peripheral neuropathy caused by chemotherapy, often called chemotherapy-induced peripheral neuropathy (CIPN). Peripheral neuropathy refers to the conditions that result when nerves that carry messages to and from the brain and spinal cord from and to the rest of the body are damaged or diseased. The TENS device emits high frequency electrical stimulation through the skin and may provide relief from chronic pain.
Research Base: University of Rochester NCORP Research Base
NCT ID: NCT04367480
NCI Protocol Number: URCC-19085
Status: Completed
For more information see ClinicalTrials.gov
Interventions
- Placebo Administration
- Questionnaire Administration
- Transcutaneous Electrical Nerve Stimulation
Condition
Chemotherapy-Induced Peripheral Neuropathy
Trial Type
Supportive Care/Symptom Management/PROs
See a list of participating sites on ClinicalTrials.gov